Biochemical Reagent
-
BA6343 MTX-211Summary: MTX-211 (Mol211) is a dual inhibitor. -
BA6344 CH7233163Summary: CH7233163 is a -Del19/T790M/C797S non-covalent ATP competitive inhibitor.
-
BA6345 BefotertinibSummary: Befotertinib (D-0316) is a third generation tyrosine kinase inhibitor.
-
BA6346 JCN037Summary: JCN037 (JGK037) is a potent, covalent inhibitor that crosses the blood-brain barrier.
-
BA6347 PF-6274484Summary: PF-6274484 was a potent inhibitor with s of 0.14 nM and 0.18 nM for EGFR-L858R/T790M and WT-EGFR, respectively.
-
BA6348 HG-14-10-04Summary: HG-14-10-04 is a potent mutation inhibitor.
-
BA6349 YK-029ASummary: YK-029A is an orally effective mutation inhibitor.
-
BA6350 TAS0728Summary: TAS0728 is a potent, selective, orally active, irreversible covalent binding inhibitor of 13 nM.
-
BA6351 OritinibSummary: SH-1028 is an irreversible third-generation that overcomes T790M-mediated resistance in non-small cell lung cancer.
-
BA6352 PDZ1iSummary: PDZ1i is a potent, blood-brain barrier-crossing, specific inhibitor.